Market News Archive

Stay updated with the latest announcements

29 Oct 2024

BXPHARMA: Dividend Declaration

The Board of Directors has recommended 40% Cash Dividend for the year ended June 30, 2024. Date of AGM: 29.12.2024, Time: 10:30 AM, Venue: Virtual Platform. Record Date: 25.11.2024. The Company has also reported consolidated EPS of Tk. 13.07, consolidated NAV per share of Tk. 107.48 and consolidated NOCFPS of Tk. 18.75 for the year ended June 30, 2024 as against Tk. 10.34, Tk. 97.91 and Tk. 13.64 respectively for the year ended June 30, 2023.

29 Oct 2024

LEGACYFOOT: Price Limit Open

There will be no price limit on the trading of the shares of the Company today (29.10.2024) following its corporate declaration.

28 Oct 2024
EXCH

DSE NEWS: Daily Turnover of Main Board

Today's (28.10.2024) Total Trades: 131,338; Volume: 173,324,996 and Turnover: Tk. 3,572.471 million.

28 Oct 2024

SSSTEEL: Postponement of Board Meeting schedule under LR 19(1)

The Company has further informed that due to unavoidable circumstances, the meeting scheduled to be held on October 28, 2024 at 6:30 PM as per LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, to consider, among others, audited financial statements of the Company for the year ended June 30, 2024, has been postponed.

28 Oct 2024

BATASHOE: Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2024 at 3:45 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2024.

28 Oct 2024

CONTININS: Sale Confirmation of a Sponsor

The company has informed that Mrs. Dolly Iqbal, a Sponsor of the Company, has completed her sale of 8,33,402 shares of the company at prevailing market price through Dhaka Stock Exchange PLC., whereas Mr. Kazi Joynuddin Ifthekhar has purchased the aforementioned 8,33,402 shares as per declaration disseminated on 20.10.2024.

28 Oct 2024

TECHNODRUG: Credit Rating Result

Emerging Credit Rating Limited (ECRL) has affirmed surveillance rating of the Company as "A-" in the long term and "ST-3" in the short term along with a Stable outlook based on audited financial statements of FY 2020-2023, Nine months unaudited financial statements up to march 31, 2024 and other quantitative information available up to the date of rating.

28 Oct 2024

LINDEBD: Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 31, 2024 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2024.

28 Oct 2024

DHAKAINS: Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 31, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2024.

28 Oct 2024

GEMINISEA: Postponement of Board Meeting schedule under LR 19(1)

The Company has further informed that due to unavoidable circumstances, the meeting scheduled to be held on October 28, 2024 at 3:00 PM as per LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, to consider, among others, audited financial statements of the Company for the year ended June 30, 2024, has been postponed.

28 Oct 2024

DSHGARME Reschedule of Board Meeting under LR 19(1)

The Company has further informed that due to unavoidable circumstances, the Board meeting under Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on October 29, 2024 at 3:30 PM instead of October 28, 2024 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.

28 Oct 2024

TB20Y1034: Resumption after Record Date

Trading of 20Y BGTB 29/10/2034 Government Securities will resume on 29.10.2024.

28 Oct 2024

TB15Y1029: Resumption after Record Date

Trading of 15Y BGTB 29/10/2029 Government Securities will resume on 29.10.2024.

28 Oct 2024

TB20Y0429: Resumption after Record Date

Trading of 20Y BGTB 29/04/2029 Government Securities will resume on 29.10.2024.

28 Oct 2024

TB20Y1028: Resumption after Record Date

Trading of 20Y BGTB 29/10/2028 Government Securities will resume on 29.10.2024.

28 Oct 2024

TB5Y0425: Resumption after Record Date

Trading of 05Y BGTB 29/04/2025 Government Securities will resume on 29.10.2024.

28 Oct 2024

TALLUSPIN: Suspension for Record date

Trading of the shares of the company will remain suspended on record date i.e., 29.10.2024.

28 Oct 2024

MITHUNKNIT: Suspension for Record date

Trading of the shares of the company will remain suspended on record date i.e., 29.10.2024.

28 Oct 2024

BANGAS: Suspension for Record date

Trading of the shares of the company will remain suspended on record date i.e., 29.10.2024.

28 Oct 2024

CVOPRL: Spot News

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 29.10.2024 to 30.10.2024 and trading of the shares of the company will remain suspended on record date i.e., 31.10.2024.

Latest Price
Workspace
AI Desk
Profile